Trials / Terminated
TerminatedNCT01452126
Minimum Effective Concentration of Ropivacaine for Brachial Plexus Block Via the Supraclavicular and Infraclavicular Approach, Femoral Nerve Block, Sciatic Nerve Block Via the Popliteal and Parasacral Approach
Minimum Effective Anesthetic Concentration of Supraclavicular Block, Infraclavicular Block, Femoral Nerve Block and Sciatic Nerve Block Via the Popliteal and Parasacral Approach
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- University of New Mexico · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a dose finding study to identify the minimum effective anesthetic concentration (MEAC) of ropivacaine to produce insensate body parts sufficient for surgery in supraclavicular and infraclavicular approaches to the brachial plexus, parasacral and popliteal approaches to the sciatic nerve, femoral nerve and transversus abdominis plane (TAP) blocks in adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine concentration | Single shot preoperative perineural injection of ropivacaine to achieve surgical anesthesia. The concentration of ropivacaine is lowered by 0.05% after every successful surgical anesthesia specific to that block and raised by 0.05% after every unsuccessful surgical anesthesia specific to that block |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2011-10-14
- Last updated
- 2016-12-19
- Results posted
- 2016-12-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01452126. Inclusion in this directory is not an endorsement.